Nagahiro currently oversees Mitsui’s investment in IHH.
IHH Healthcare Berhad will appoint Tomo Nagahiro as non independent and non executive alternate director, according to a filing in SGX.
Nagahiro is currently the general manager of healthcare business 1st department in healthcare
business division at Mitsui, overseeing its investment in IHH.
He has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. Preceding his current appointment at Mitsui, he was seconded to drug information and medical education multichannel provider MIMS as the Chief Operating Officer from 2015 to 2018.
Do you know more about this story? Contact us anonymously through this link.